CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 884546
SAN FRANCISCO, CA
Position in HRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$523,509
-$577,584 QoQ
Shares Held
1,217,463
-11.5% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. HRTX ranks #258 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $523,509 | 1,217,463 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,101,093 | 1,376,367 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,839,936 | 1,415,336 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,609,071 | 1,277,041 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,455,268 | 1,186,120 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,396,787 | 1,089,449 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,691,878 | 1,105,803 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,181,806 | 1,096,385 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,982,286 | 1,137,796 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,022,452 | 1,091,138 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,695,241 | 997,201 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,012,499 | 983,009 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $862,551 | 743,579 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,104,000 | 731,126 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,995,112 | 798,045 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,127,045 | 741,006 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,039,643 | 731,055 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,091,550 | 715,306 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,356,826 | 696,257 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,445,862 | 696,526 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,893,161 | 637,446 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,233,394 | 569,611 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,722,696 | 553,741 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,048,504 | 543,084 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,940,987 | 539,836 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $5,851,920 | 498,460 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||